Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
Open accessThe DOI matches its Crossref record; 111 of the 112 references it cites were found in a registry or an index.
Abstract
Glucagon-like peptide 1 (GLP-1) is a hormone secreted predominantly by the distal small intestine and colon and released in response to enteral nutrient exposure. GLP-1-based therapies are now used widely in the management of type 2 diabetes and have the potential to be effective antiobesity agents. Although widely known as an incretin hormone, there is a growing body of evidence that GLP-1 also acts as an enterogastrone, with profound effects on the gastrointestinal motor system. Moreover, the effects of GLP-1 on gastrointestinal motility appear to be pivotal to its effect of reducing postprandial glycaemic excursions and may, potentially, represent the dominant mechanism. This review summarizes current knowledge of the enterogastrone properties of GLP-1, focusing on its effects on gut motility at physiological and pharmacological concentrations, and the motor actions of incretin-based therapies. While of potential importance, the inhibitory action of GLP-1 on gastric acid secretion is beyond the scope of this paper.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Blood glucose (a) and plasma insulin (b) concentrations during IV infusion of GLP-1, at 0.3 and 0.9 pmol/kg/minutes, or 0.9% saline, in 10 healthy humans. Data are means ± SEM. *GLP-1 0.3 and 0.9 versus saline: P < .05; #GLP-1 0.9 versus GLP-1 0.3: P < .05 (adapted from Little et al. 2006 [19], and used with permission from the publisher).](https://figures.cochat.ai/paper-figures/12ab264a4ad24a26a6cba2d995beab18/effects-of-glp-1-and-incretin-based-therapies-on-gastrointestinal-motor-function-figure-1.jpg)
![Figure 2 Relationship between the area under the plasma glucose concentration curve between 0 and 30 minutes and the retention of the meal in the stomach at 30 minutes (r = 0.65, P < .01) (adapted from Horowitz et al. 1993 [45] and used with the permission of the publisher).](https://figures.cochat.ai/paper-figures/9c0d556b035e4aa9a9b1a00b73ec14a4/effects-of-glp-1-and-incretin-based-therapies-on-gastrointestinal-motor-function-figure-2.jpg)
![Figure 3 Gastric emptying curves for the solid and liquid components of a meal for the total, proximal, and distal stomach during IV infusion of GLP-1 at 0.3 and 0.9 pmol/kg/minutes, or 0.9% saline, in 10 healthy humans. Data are means ± SEM. *GLP-1 0.3 and 0.9 versus saline: P < .05; #GLP-1 0.9 versus GLP-1 0.3: P < .05 (adapted from Little et al. 2006 [19] and used with permission from the publisher).](https://figures.cochat.ai/paper-figures/ce9fce815c1442429bc48b6a23974b19/effects-of-glp-1-and-incretin-based-therapies-on-gastrointestinal-motor-function-figure-3.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“GLP-1 RAs delay gastric emptying by inhibiting gastrointestinal motility through both PNS and CNS.”
From Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia (2026) · cites this paper as [29]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consequently, this promotes fundic relaxation, decreases peristalsis in the gastric antrum and duodenum, and increases pyloric sphincter tone, thereby delaying the transfer of gastric contents into the duodenum [29].”
From Delayed gastric emptying induced by glucagon-like peptide-1 receptor agonists and its implications for perioperative risk during anesthesia (2026) · cites this paper as [29]
Experimental — accuracy not yet measuredIn the citing paper
“Constipation tended to last longer, and may be because of the effects of GLP‐1RAs on GI motility. 22”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Nauck, M. A., Heimesaat, M. M., Orskov, C., Holst, J. J., Ebert, R., & Creutzfeldt, W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116186 · Cited by 1,651
The mechanism of pancreatic secretion
Bayliss, W. M., & Starling, E. H. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000920 · Cited by 1,269
Drucker, D. J., Buse, J. B., Taylor, K., Kendall, D. M., Trautmann, M., Zhuang, D., & Porter, L. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61206-4 · Cited by 1,070 · cited 2×
“While these could relate to its effects on gastric motor function, and antral distension in particular [35, 36, 97], the occurrence of adverse effects seems not to relate closely to the delay in gastric emptying [81, 96], and it is possible that central mechanisms are important.”
BackgroundGut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1.
Jang, H.-J., Kokrashvili, Z., Theodorakis, M. J., Carlson, O. D., Kim, B.-J., Zhou, J., Kim, H. H., Xu, X., Chan, S. L., Juhaszova, M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706890104 · Cited by 995
Postprandial Hyperglycemia and Diabetes Complications
Ceriello, A. (2005) · Diabetes · doi:10.2337/diabetes.54.1.1 · Cited by 945 · cited 1×
“Postprandial hyperglycaemia is being increasingly recognised as an independent predictor of cardiovascular mortality in both diabetic and nondiabetic populations [55, 56].”
BackgroundVilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Plasma Insulin Response to Oral and Intravenous Glucose Administration1
ELRICK, H., STIMMLER, L., HLAD, C. J., & ARAI, Y. (1964) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-24-10-1076 · Cited by 857
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · cited 1×
“The insulinotropic property of GIP is markedly diminutesished in type 2 diabetic patients [89–91], probably in part as an effect of hyperglycaemia.”
BackgroundNauck, M. A., Niedereichholz, U., Ettler, R., Holst, J. J., Ørskov, C., Ritzel, R., & Schmiegel, W. H. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.5.e981 · Cited by 817
New Interpretation of Oral Glucose Tolerance
Mcintyre, N., Holdsworth, C. D., & Turner, D. S. (1964) · The Lancet · doi:10.1016/s0140-6736(64)90011-x · Cited by 738 · cited 1×
“[7] in 1964, that an oral glucose load resulted in a much greater insulin response than an intravenous glucose load despite resulting in comparable blood glucose concentrations—the so-called “incretin effect” [8].”
BackgroundCreutzfeldt, W. (1979) · Diabetologia · doi:10.1007/bf01225454 · Cited by 731
Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1380159 · Cited by 695
Single photon-emission computed tomography
Holly, T. A., Abbott, B. G., Al-Mallah, M., Calnon, D. A., Cohen, M. C., DiFilippo, F. P., Ficaro, E. P., Freeman, M. R., Hendel, R. C., Jain, D., et al. (2010) · Journal of Nuclear Cardiology · doi:10.1007/s12350-010-9246-y · Cited by 597
Hyperglycaemia slows gastric emptying in Type 1 (insulin-dependent) diabetes mellitus
Fraser, R. J., Horowitz, M., Maddox, A. F., Harding, P. E., Chatterton, B. E., & Dent, J. (1990) · Diabetologia · doi:10.1007/bf00400569 · Cited by 496
Self-citationInteractions of Glucagon-Like Peptide-1 (GLP-1) with the Blood-Brain Barrier
Kastin, A. J., Akerstrom, V., & Pan, W. (2002) · Journal of Molecular Neuroscience · doi:10.1385/jmn:18:1-2:07 · Cited by 480
Relationship between oral glucose tolerance and gastric emptying in normal healthy subjects
Horowitz, M., Edelbroek, M. A. L., Wishart, J. M., & Straathof, J. W. (1993) · Diabetologia · doi:10.1007/bf00400362 · Cited by 469 · cited 3×
“Gastric emptying is a major determinutesant of postprandial glycaemic excursions in healthy subjects [45] as well as type 1 and type 2 diabetic patients [46] so that slower gastric emptying is associated with reduction in blood glucose, especially in the first hour after ingestion of a meal [58, 59] (Figure 2).”
BackgroundMethodSelf-citationRelationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Rayner, C. K., Samsom, M., Jones, K. L., & Horowitz, M. (2001) · Diabetes Care · doi:10.2337/diacare.24.2.371 · Cited by 460
Self-citationKolterman, O. G., Kim, D. D., Shen, L., Ruggles, J. A., Nielsen, L. L., Fineman, M. S., & Baron, A. D. (2005) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/62.2.173 · Cited by 434
Bonora, E., & Muggeo, M. (2001) · Diabetologia · doi:10.1007/s001250100020 · Cited by 420
Schvarcz, E., Palmer, M., Aman, J., Horowitz, M., Stridsberg, M., & Berne, C. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70080-5 · Cited by 416
Self-citationMuscelli, E., Mari, A., Casolaro, A., Camastra, S., Seghieri, G., Gastaldelli, A., Holst, J. J., & Ferrannini, E. (2008) · Diabetes · doi:10.2337/db07-1315 · Cited by 409
Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP
Theodorakis, M. J., Carlson, O., Michopoulos, S., Doyle, M. E., Juhaszova, M., Petraki, K., & Egan, J. M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00326.2004 · Cited by 396
Gastric and oesophageal emptying in patients with Type 2 (non-insulin-dependent) diabetes mellitus
Horowitz, M., Harding, P. E., Maddox, A. F., Wishart, J. M., Akkermans, L. M. A., Chatterton, B. E., & Shearman, D. J. C. (1989) · Diabetologia · doi:10.1007/bf00265086 · Cited by 392
Self-citationBaggio, L. L., Huang, Q., Brown, T. J., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.9.2492 · Cited by 386
DeFronzo, R. A., Okerson, T., Viswanathan, P., Guan, X., Holcombe, J. H., & MacConell, L. (2008) · Current Medical Research and Opinion · doi:10.1185/03007990802418851 · Cited by 373
Meier, J. J., Gallwitz, B., Salmen, S., Goetze, O., Holst, J. J., Schmidt, W. E., & Nauck, M. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030049 · Cited by 369
Mari, A., Sallas, W. M., He, Y. L., Watson, C., Ligueros-Saylan, M., Dunning, B. E., Deacon, C. F., Holst, J. J., & Foley, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2460 · Cited by 361
Vollmer, K., Holst, J. J., Baller, B., Ellrichmann, M., Nauck, M. A., Schmidt, W. E., & Meier, J. J. (2008) · Diabetes · doi:10.2337/db07-1124 · Cited by 356
Näslund, E., Gutniak, M., Skogar, S., Rössner, S., & Hellström, P. M. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.3.525 · Cited by 307
Ørskov, C., Poulsen, S. S., Mørten, M., & Holst, J. J. (1996) · Diabetes · doi:10.2337/diab.45.6.832 · Cited by 304
Nauck, M. A. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2010.11.002 · Cited by 295
On the treatment of Diabetus mellitus by acid extract of Duodenal Mucous Membrane
Moore, B., Edie, E. S., & Abram, J. H. (1906) · Biochemical Journal · doi:10.1042/bj0010028 · Cited by 279
Schirra, J., Nicolaus, M., Roggel, R., Katschinski, M., Storr, M., Woerle, H. J., & Göke, B. (2006) · Gut · doi:10.1136/gut.2004.059741 · Cited by 277
Further purification of a polypeptide demonstrating enterogastrone activity
Brown, J. C., Mutt, V., & Pederson, R. A. (1970) · The Journal of Physiology · doi:10.1113/jphysiol.1970.sp009155 · Cited by 276
Juhl, C. B., Hollingdal, M., Sturis, J., Jakobsen, G., Agersø, H., Veldhuis, J., Pørksen, N., & Schmitz, O. (2002) · Diabetes · doi:10.2337/diabetes.51.2.424 · Cited by 264
Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Linnebjerg, H., Park, S., Kothare, P. A., Trautmann, M. E., Mace, K., Fineman, M., Wilding, I., Nauck, M., & Horowitz, M. (2008) · Regulatory Peptides · doi:10.1016/j.regpep.2008.07.003 · Cited by 261 · cited 5×
“Exenatide slows gastric emptying of both solid and liquid components of a meal, irrespective of the presence of established autonomic neuropathy [81].”
BackgroundInfluentialSelf-citationEffect of meal volume and energy density on the gastric emptying of carbohydrates
Hunt, J. N., Smith, J. L., & Jiang, C. L. (1985) · Gastroenterology · doi:10.1016/0016-5085(85)90650-x · Cited by 253
Deane, A. M., Nguyen, N. Q., Stevens, J. E., Fraser, R. J. L., Holloway, R. H., Besanko, L. K., Burgstad, C., Jones, K. L., Chapman, M. J., Rayner, C. K., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1503 · Cited by 238
Self-citationDelgado-Aros, S., Kim, D.-Y., Burton, D. D., Thomforde, G. M., Stephens, D., Brinkmann, B. H., Vella, A., & Camilleri, M. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2002.282.3.g424 · Cited by 235 · cited 2×
“Gastric relaxation [68, 105] and postprandial gastric accommodation [68], in response to exogenous GLP-1, are mediated by vagal cholinergic pathways; antro-pyloro-duodenal motility apparently is not [103].”
BackgroundBouras, E. P., Delgado-Aros, S., Camilleri, M., Castillo, E. J., Burton, D. D., Thomforde, G. M., & Chial, H. J. (2002) · Gut · doi:10.1136/gut.51.6.781 · Cited by 218
Little, T. J., Pilichiewicz, A. N., Russo, A., Phillips, L., Jones, K. L., Nauck, M. A., Wishart, J., Horowitz, M., & Feinle-Bisset, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2220 · Cited by 212
Self-citationMediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins
Hasler, W. L., Soudah, H. C., Dulai, G., & Owyang, C. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90445-x · Cited by 211
Vella, A., Bock, G., Giesler, P. D., Burton, D. B., Serra, D. B., Saylan, M. L., Dunning, B. E., Foley, J. E., Rizza, R. A., & Camilleri, M. (2007) · Diabetes · doi:10.2337/db07-0136 · Cited by 201
Pilichiewicz, A. N., Chaikomin, R., Brennan, I. M., Wishart, J. M., Rayner, C. K., Jones, K. L., Smout, A. J. P. M., Horowitz, M., & Feinle-Bisset, C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00159.2007 · Cited by 195
Self-citationRelation between postprandial satiation and antral area in normal subjects
Jones, K., Doran, S., Hveem, K., Bartholomeusz, F., Morley, J., Sun, W., Chatterton, B., & Horowitz, M. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/66.1.127 · Cited by 194
Self-citationEnergy intake and appetite are related to antral area in healthy young and older subjects
Sturm, K., Parker, B., Wishart, J., Feinle-Bisset, C., Jones, K. L., Chapman, I., & Horowitz, M. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.656 · Cited by 184
Self-citationHveem, K., Jones, K. L., Chatterton, B. E., & Horowitz, M. (1996) · Gut · doi:10.1136/gut.38.6.816 · Cited by 180
Self-citationWelch, I. M., Sepple, C. P., & Read, N. W. (1988) · Gut · doi:10.1136/gut.29.3.306 · Cited by 180
Development of a test to measure gastric accommodation in humans
Kuiken, S. D., Samsom, M., Camilleri, M., Mullan, B. P., Burton, D. D., Kost, L. J., Hardyman, T. J., Brinkmann, B. H., & O'connor, M. K. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.277.6.g1217 · Cited by 178
Katsuma, S., Hatae, N., Yano, T., Ruike, Y., Kimura, M., Hirasawa, A., & Tsujimoto, G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412385200 · Cited by 178
Gastric emptying in early noninsulin-dependent diabetes mellitus.
Jones, K. L., Horowitz, M., Carney, B. I., Wishart, J. M., Guha, S., & Green, L. (1996) · PubMed · Cited by 175
Self-citationHyperglycaemia stimulates pyloric motility in normal subjects.
Fraser, R., Horowitz, M., & Dent, J. (1991) · Gut · doi:10.1136/gut.32.5.475 · Cited by 173
Self-citationThe physiological role of GLP-1 in human: incretin, ileal brake or more?
Schirra, J. R. J., & Göke, B. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.06.018 · Cited by 166
Edholm, T., Degerblad, M., Grybäck, P., Hilsted, L., Holst, J. J., Jacobsson, H., Efendic, S., Schmidt, P. T., & Hellström, P. M. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01554.x · Cited by 164 · cited 1×
“If anything, there is some evidence that GIP may modestly accelerate emptying from the stomach [18].”
BackgroundDeterminants of the Effectiveness of Glucagon-Like Peptide-1 in Type 2 Diabetes
Toft-Nielsen, M.-B., Madsbad, S., & Holst, J. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7743 · Cited by 164
Hellström, P. M., Näslund, E., Edholm, T., Schmidt, P. T., Kristensen, J., Theodorsson, E., Holst, J. J., & Efendic, S. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01079.x · Cited by 160
Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient
Lin, H. C., Doty, J. E., Reedy, T. J., & Meyer, J. H. (1990) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1990.259.6.g1031 · Cited by 156
Thumshirn, M., Camilleri, M., Saslow, S. B., Williams, D. E., Burton, D. D., & Hanson, R. B. (1999) · Gut · doi:10.1136/gut.44.1.55 · Cited by 152
Meier, J. J., Kemmeries, G., Holst, J. J., & Nauck, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2212 · Cited by 146
Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
Nauck, M. A., Holst, J. J., Willms, B., & Schmiegel, W. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211750 · Cited by 145
Schirra, J., Houck, P., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2000) · Gut · doi:10.1136/gut.46.5.622 · Cited by 145
Ma, J., Chang, J., Checklin, H. L., Young, R. L., Jones, K. L., Horowitz, M., & Rayner, C. K. (2010) · British Journal of Nutrition · doi:10.1017/s0007114510001327 · Cited by 141
Self-citationZunz, E., & Jean, L. B. (1929) · Archives Internationales de Physiologie · doi:10.1080/13813455.1929.11864670 · Cited by 140
Tolessa, T., Gutniak, M., Holst, J. J., Efendic, S., & Hellström, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci942 · Cited by 139
Schirra, J., Wank, U., Arnold, R., Göke, B., & Katschinski, M. (2002) · Gut · doi:10.1136/gut.50.3.341 · Cited by 130
Little, T. J., Doran, S., Meyer, J. H., Smout, A. J. P. M., O'Donovan, D. G., Wu, K.-L., Jones, K. L., Wishart, J., Rayner, C. K., Horowitz, M., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00099.2006 · Cited by 130
Self-citationMannucci, E., Tesi, F., Bardini, G., Ognibene, A., Mg, P., Ciani, S., Pezzatini, A., Brogi, M., Dicembrini, I., Cremasco, F., et al. (2004) · PubMed · Cited by 128
Gastric inhibitory polypeptide does not inhibit gastric emptying in humans
Meier, J. J., Goetze, O., Anstipp, J., Hagemann, D., Holst, J. J., Schmidt, W. E., Gallwitz, B., & Nauck, M. A. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00499.2003 · Cited by 126
Amato, A., Cinci, L., Rotondo, A., Serio, R., Faussone-pellegrini, M. S., Vannucchi, M. G., & Mulè, F. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01476.x · Cited by 124
The [pre-] history of the incretin concept
Creutzfeldt, W. (2004) · Regulatory Peptides · doi:10.1016/j.regpep.2004.08.004 · Cited by 123
O’Donovan, D. G., Doran, S., Feinle-Bisset, C., Jones, K. L., Meyer, J. H., Wishart, J. M., Morris, H. A., & Horowitz, M. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0334 · Cited by 122
Self-citationGonlachanvit, S., Hsu, C.-W., Boden, G. H., KNIGHT, L. C., Maurer, A. H., Fisher, R. S., & Parkman, H. P. (2003) · Digestive Diseases and Sciences · doi:10.1023/a:1022528414264 · Cited by 119
Cvetkovi, R. S., & Plosker, G. L. (2007) · Drugs · doi:10.2165/00003495-200767060-00008 · Cited by 117
Is glucagon-like peptide 1 an incretin hormone?
Nauck, M. A. (1999) · Diabetologia · doi:10.1007/s001250051165 · Cited by 112
Russo, A., Stevens, J. E., Chen, R., Gentilcore, D., Burnet, R., Horowitz, M., & Jones, K. L. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0513 · Cited by 112
Self-citationSalehi, M., Vahl, T. P., & D'Alessio, D. A. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0605 · Cited by 108 · cited 1×
“Three other studies employing exendin (9-39) failed to show an effect of endogenous GLP-1 on gastric emptying [86–88], but this is likely to reflect methodological differences, including the use of a suboptimal technique (plasma D-xylose) for measuring gastric emptying in one study [87].”
BackgroundDeane, A. M., Chapman, M. J., Fraser, R. J. L., Summers, M. J., Zaknic, A. V., Storey, J. P., Jones, K. L., Rayner, C. K., & Horowitz, M. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181d9d87a · Cited by 104
Self-citationMacGregor, I. L., Martin, P., & Meyer, J. (1977) · Gastroenterology · doi:10.1016/s0016-5085(77)80073-5 · Cited by 101
Chemical specificities and intestinal distributions of nutrient-driven satiety
Meyer, J. H., Hlinka, M., Tabrizi, Y., DiMaso, N., & Raybould, H. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.4.r1293 · Cited by 99
Jones, K. L., Berry, M., Kong, M. F., Kwiatek, M. A., Samsom, M., & Horowitz, M. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.339 · Cited by 98
Self-citationHebbard, G. S., Samsom, M., Sun, W. M., Dent, J., & Horowitz, M. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.5.g814 · Cited by 93
Self-citationHELLSTRÖM, P. M., HEIN, J., BYTZER, P., BJÖRNSSÖN, E., KRISTENSEN, J., & SCHAMBYE, H. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03870.x · Cited by 91
Diabetic Gastroparesis: Diagnosis and Management
Ma, J., Rayner, C. K., Jones, K. L., & Horowitz, M. (2009) · Drugs · doi:10.2165/00003495-200969080-00003 · Cited by 87
Self-citationAcarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly
Gentilcore, D., Bryant, B., Wishart, J. M., Morris, H. A., Horowitz, M., & Jones, K. L. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.05.019 · Cited by 83
Self-citationGlucagonlike Peptide-1 (GLP-1) Participation in Ileal Brake Induced by Intraluminal Peptones in Rat
Giralt, M., & Vergara, P. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026654417697 · Cited by 82
Blase, E., Taylor, K., Gao, H., Wintle, M., & Fineman, M. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004274432 · Cited by 82 · cited 2×
“Exenatide, derived from the saliva of the Gila monster Heloderma suspectum, has been shown to induce a dose-dependent deceleration of gastric emptying in healthy subjects [80] and type 2 diabetic patients [82, 94].”
BackgroundGedulin, B. R., Smith, P., Prickett, K. S., Tryon, M. S., Barnhill, S. D., Reynolds, J., Nielsen, L. L., Parkes, D. G., & Young, A. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1795-2 · Cited by 82
GLP‐1 regulates gastroduodenal motility involving cholinergic pathways
Schirra, J., Nicolaus, M., Woerle, H. J., Struckmeier, C., Katschinski, M., & Göke, B. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01246.x · Cited by 77
Delgado‐Aros, S., Vella, A., Camilleri, M., Low, P. A., Burton, D. D., Thomforde, G. M., & Stephens, D. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00422.x · Cited by 77
Read, N. W., Al-Janabi, M., Edwards, C. A., & Barber, D. C. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80122-5 · Cited by 75
Nicolaus, M., Brödl, J., Linke, R., Woerle, H.-J., Göke, B., & Schirra, J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0841 · Cited by 73
Schirra, J., Leicht, P., Hildebrand, P., Beglinger, C., Arnold, R., Goke, B., & Katschinski, M. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1560177 · Cited by 65
Gastrointestinal motility and glycemic control in diabetes: the chicken and the egg revisited?
Rayner, C. K. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27758 · Cited by 65
Self-citationImportance of changes in gastric emptying for postprandial plasma glucose fluxes in healthy humans
Woerle, H.-J., Albrecht, M., Linke, R., Zschau, S., Neumann, C., Nicolaus, M., Gerich, J., Göke, B., & Schirra, J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2007 · Cited by 62
Vella, A., Bock, G., Giesler, P. D., Burton, D. B., Serra, D. B., Saylan, M. L., Deacon, C. F., Foley, J. E., Rizza, R. A., & Camilleri, M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03235.x · Cited by 61
Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes
St Onge, E. L., & Miller, S. A. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.481281 · Cited by 61
Length of intestinal contact on nutrient-driven satiety
Meyer, J. H., Tabrizi, Y., DiMaso, N., Hlinka, M., & Raybould, H. E. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.4.r1308 · Cited by 60
GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat
Bozkurt, A., Näslund, E. B., Holst, J. J., & Hellström, P. M. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00095-2 · Cited by 59
Liraglutide in the management of type 2 diabetes
Wajcberg, E., & Amarah, A. R. (2010) · Drug Design Development and Therapy · doi:10.2147/dddt.s10180 · Cited by 54
Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats
Gülpinar, M. A., Bozkurt, A., Coşkun, T., Ulusoy, N. B., & Yeǧen, B. Ç. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.6.g924 · Cited by 48
Chaikomin, R., Wu, K. L., Doran, S., Jones, K. L., Smout, A. J. P. M., Renooij, W., Holloway, R. H., Meyer, J. H., Horowitz, M., & Rayner, C. K. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00519.2006 · Cited by 47
Self-citationPala, L., Ciani, S., Dicembrini, I., Bardini, G., Cresci, B., Pezzatini, A., Giannini, S., Mannucci, E., & Rotella, C. M. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.03010.x · Cited by 46
Brubaker, P. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3078 · Cited by 44
Byrne, M. M., McGregor, G. P., Barth, P., Rothmund, M., Göke, B., & Arnold, R. (2001) · Digestion · doi:10.1159/000051874 · Cited by 39
Gastrointestinal function in diabetes mellitus
Horowitz, M., & Samsom, M. (2004) · Wiley eBooks · Cited by 36
Self-citationTo be or not to be—an incretin or enterogastrone?
Horowitz, M., & Nauck, M. A. (2006) · Gut · doi:10.1136/gut.2005.071787 · Cited by 35
Self-citationWitte, A.-B., Grybäck, P., Jacobsson, H., Näslund, E., Hellström, P. M., Holst, J. J., Hilsted, L., & Schmidt, P. T. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.537680 · Cited by 33
Oehme, C., & Wimmers, K. (1923) · Research in Experimental Medicine · doi:10.1007/bf02622931 · Cited by 15
Takács, L. (1927) · Clinical and Experimental Medicine · doi:10.1007/bf02610248 · Cited by 11
Research works printed but not linked: 14
- 1964, The Lancet, 284, 20
- 1997, American Journal of Physiology, 273, E981
- 2010, Neurogastroenterology & Motility, 22, article e1315, 1191
- 2004, Diabetes, Nutrition & Metabolism, 17, 336
- 1999, American Journal of Physiology, 277, G1217
- 1990, American Journal of Physiology, 259, G1031
- 1998, American Journal of Physiology, 275, R1293
- 1998, American Journal of Physiology, 275, R1308
- 1996, Journal of Nuclear Medicine, 37, 1643
- 1996, American Journal of Physiology, 271, G814
- 2002, American Journal of Physiology, 282, G424
- 2000, American Journal of Physiology, 278, G924
- 2010, Journal of Drug Design, Development and Therapy, 4, 279
- 2003, Diabetes, 52, A322
Cited by
Filippatos, T. D., Panagiotopoulou, T. V., & Elisaf, M. S. (2014) · The Review of Diabetic Studies · Cited by 560
Microbial Modulation of Energy Availability in the Colon Regulates Intestinal Transit
Wichmann, A., Allahyar, A., Greiner, T. U., Plovier, H., Lundén, G. Ö., Larsson, T., Drucker, D. J., Delzenne, N. M., Cani, P. D., & Bäckhed, F. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.09.012 · Cited by 380
Kanasaki, K., Shi, S., Kanasaki, M., He, J., Nagai, T., Nakamura, Y., Ishigaki, Y., Kitada, M., Srivastava, S. P., & Koya, D. (2014) · Diabetes · doi:10.2337/db13-1029 · Cited by 359
Gorgojo-Martínez, J. J., Mezquita-Raya, P., Carretero-Gómez, J., Castro, A., Cebrián-Cuenca, A., de Torres-Sánchez, A., García-de-Lucas, M. D., Núñez, J., Obaya, J. C., Soler, M. J., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm12010145 · Cited by 358
Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS
van Bloemendaal, L., ten Kulve, J. S., la Fleur, S. E., Ijzerman, R. G., & Diamant, M. (2014) · Journal of Endocrinology · doi:10.1530/joe-13-0414 · Cited by 312
“The role of gastric motility in appetite and satiation regulation and the effects of GLP-1/GLP-1RA on gastric and gut motility has been extensively reviewed (Janssen et al. 2011, Marathe et al. 2011).”
Metadata
- Authors
- Marathe, C. S., Rayner, C. K., Jones, K. L., & Horowitz, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- Corresponding author
- Rayner, Christopher K.
- Venue
- Experimental Diabetes Research
- Publisher
- Wiley
- Published
- 2011
- Volume
- 2011
- Pages
- 1-10
- ISSN
- 1687-5214 (ISSN-L)
- 1687-5303
- PMC
- PMC3124003
- OpenAlex
- W2065444806
- Cited by
- 138
- References
- 112
- Citations by year
- 2026: 16 · 2025: 18 · 2024: 20 · 2023: 3 · 2022: 6 · 2021: 11 · 2020: 11 · 2019: 10 · 2018: 6 · 2017: 3 · 2016: 6 · 2015: 9 · 2014: 6 · 2013: 12 · 2012: 1
- FWCI
- 4.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Experimental Diabetes Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- UniSA Research Outputs Repository (University of South Australia) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon-like peptide-1, incretin-based therapy, gastrointestinal motility, enterogastrone, type 2 diabetes, anti-obesity, gastric emptying, gastric acid secretion
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Gastrointestinal Hormones, Gastrointestinal Motility, Humans, Movement, Peptides, Gastrointestinal Tract, Glucagon-Like Peptide 1, Incretins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.